P

Protagonist Therapeutics
D

PTGX

41.660
USD
0.83
(2.03%)
مفتوح الان
حجم التداول
8,284
الربح لكل سهم
-1
العائد الربحي
-
P/E
10
حجم السوق
2,557,269,480
أصول ذات صلة
B
BEAM
0.210
(1.43%)
14.860 USD
B
BLUE
-0.13000
(-2.77%)
4.56000 USD
C
CRSP
1.740
(5.06%)
36.130 USD
E
EDIT
0.04500
(4.05%)
1.15500 USD
GILD
GILD
1.310
(1.29%)
102.690 USD
MRNA
MRNA
0.770
(3.15%)
25.250 USD
N
NTLA
0.17000
(2.51%)
6.93000 USD
VRTX
VRTX
1.74
(0.37%)
476.75 USD
المزيد
الأخبار المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.